546 related articles for article (PubMed ID: 11129126)
1. Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.
Hvizdos KM; Jarvis B
Drugs; 2000 Nov; 60(5):1141-78. PubMed ID: 11129126
[TBL] [Abstract][Full Text] [Related]
2. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group.
Mellon M
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):191-9. PubMed ID: 10518846
[TBL] [Abstract][Full Text] [Related]
4. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
5. Budesonide inhalation suspension for the treatment of asthma in infants and children.
Berger WE
Drugs; 2005; 65(14):1973-89. PubMed ID: 16162021
[TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth.
Axelsson I; Naumburg E; Prietsch SO; Zhang L
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010126. PubMed ID: 31194879
[TBL] [Abstract][Full Text] [Related]
7. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
[TBL] [Abstract][Full Text] [Related]
8. Once-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.
Scott MB; Ellis MH; Cruz-Rivera M; Fitzpatrick S; Smith JA
Ann Allergy Asthma Immunol; 2001 Dec; 87(6):488-95. PubMed ID: 11770696
[TBL] [Abstract][Full Text] [Related]
9. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
Jarvis B; Faulds D
Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
White MV; Cruz-Rivera M; Walton-Bowen K
Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
[TBL] [Abstract][Full Text] [Related]
11. Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma.
Szefler SJ; Eigen H
J Allergy Clin Immunol; 2002 Apr; 109(4):730-42. PubMed ID: 11941331
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
13. A review of budesonide inhalation suspension in the treatment of pediatric asthma.
Szefler SJ
Pharmacotherapy; 2001 Feb; 21(2):195-206. PubMed ID: 11213857
[TBL] [Abstract][Full Text] [Related]
14. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
15. Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study.
Reddel HK; Busse WW; Pedersen S; Tan WC; Chen YZ; Jorup C; Lythgoe D; O'Byrne PM
Lancet; 2017 Jan; 389(10065):157-166. PubMed ID: 27912982
[TBL] [Abstract][Full Text] [Related]
16. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants.
Baker JW; Mellon M; Wald J; Welch M; Cruz-Rivera M; Walton-Bowen K
Pediatrics; 1999 Feb; 103(2):414-21. PubMed ID: 9925834
[TBL] [Abstract][Full Text] [Related]
17. Optimizing inhaled corticosteroid therapy in children with chronic asthma.
O'Connell EJ
Pediatr Pulmonol; 2005 Jan; 39(1):74-83. PubMed ID: 15532098
[TBL] [Abstract][Full Text] [Related]
18. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
Sharpe M; Jarvis B
Drugs; 2001; 61(9):1325-50. PubMed ID: 11511026
[TBL] [Abstract][Full Text] [Related]
19. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children.
Kemp JP; Skoner DP; Szefler SJ; Walton-Bowen K; Cruz-Rivera M; Smith JA
Ann Allergy Asthma Immunol; 1999 Sep; 83(3):231-9. PubMed ID: 10507269
[TBL] [Abstract][Full Text] [Related]
20. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
